Pet Cancer Therapeutics Market Research Report 2023-2028 |
Posted: June 1, 2023 |
IMARC Group, a leading market research company, has recently releases report titled “Pet Cancer Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global pet cancer therapeutics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. How big is the pet cancer therapeutics market? The global pet cancer therapeutics market size reached US$ 268.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 473.1 Million by 2028, exhibiting a growth rate (CAGR) of 9.97% during 2023-2028. What is pet cancer therapeutics? Pet cancer therapeutics represent the diagnosis and treatment alternatives for tumor and cancerous growth in domesticated animals. It involves the treatment of mast cell cancer, melanoma lymphoma, and mammary and squamous cell cancer in cats, dogs, and other pet animals. Commonly used pet cancer therapeutics include immunotherapy, radiation therapy, chemotherapy, and biopsy. These cures gradually shrink or neutralize the cancer cells using plant- and bacteria-based drugs and stop the tumor from affecting other body parts. The drugs are injected intravenously or administered orally, under the skin, or into the cancer or a muscle. The medicines are mixed with the food or treat to hide the flavor and make it more appealing to the animals. Pet cancer therapeutics find widespread applications across veterinary hospitals, clinics, and retail and online pharmacies. Request for a free sample copy of this report: https://www.imarcgroup.com/pet-cancer-therapeutics-market/requestsample Market Trends: The escalating prevalence of tumors in animals across the globe is among the primary factors driving the pet cancer therapeutics market. Besides this, the presence of leukemia and lymphoma in certain breeds of aging dogs and cats that are caused by prolonged exposure to second-hand tobacco smoke, herbicides, ultraviolet (UV) rays, pesticides, insecticides, and air pollution is further augmenting the market growth. Moreover, the rising domestication of animals and the increasing awareness toward the benefits of timely diagnosis and available treatment options are also catalyzing the global market. Apart from this, various technological advancements, such as the introduction of highly specific and targeted therapies for animal cancer with minimal side effects, are acting as significant growth-inducing factors. Furthermore, the inflating expenditure capacities of the consumers on animal healthcare and the extensive research and development (R&D) activities in the field of veterinary oncology are anticipated to propel the pet cancer therapeutics market over the forecasted period. Competitive Analysis and Segmentation: Pet Cancer Therapeutics Key Players:
Report Segmentation: The report has segmented the market into the following categories: Breakup by Therapy:
Breakup by Animal Species:
Breakup by Cancer Type:
Breakup by End User:
Breakup by Region:
Explore Full Report Description At: https://www.imarcgroup.com/pet-cancer-therapeutics-market Key Highlights of the Report:
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization. About Us: IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. Contact US IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA USA: +1-631-791-1145 | Asia: +91-120-433-0800 Email: [email protected] Follow us on Twitter: @imarcglobal LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/ Read Newsletter: https://www.linkedin.com/newsletters/industry-news-about-6929400456628637696
|
||||||||||||||||||||||||||||||||||||||||||
|